MassChallenge Startups Create Impact


Startups Accelerated


Funding Raised


Revenue Generated


Jobs Created

Our startups

Be inspired. Search our startups.

ViThera Laboratories
ViThera Laboratories

ViThera develops new drugs based on engineered beneficial bacteria. Our lead product VT201 targets IBD, such as Crohn's or Colitis, a significant unmet need, and addresses a $10bn/yr market. VT201 is a food strain bacterium (Lactococcus Lactis, typical component of cheese) engineered to express an anti-inflammatory protein which controls inflammation in the gut-after oral intake of the therapeutic bacteria. We have a uniquely experienced team and strong exclusive IP position.
ViThera develops new drugs based on engineered beneficial bacteria

Connect with ViThera Laboratories


2010 Silver Boston

2010 Top 26

Sub industry

Healthcare / Life Sciences


MassChallenge strengthens the global innovation ecosystem by accelerating high-potential startups across all industries, from anywhere in the world.